These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa. Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650 [TBL] [Abstract][Full Text] [Related]
43. Quorum sensing in Pseudomonas aeruginosa biofilms. de Kievit TR Environ Microbiol; 2009 Feb; 11(2):279-88. PubMed ID: 19196266 [TBL] [Abstract][Full Text] [Related]
44. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa. Delissalde F; Amábile-Cuevas CF Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270 [TBL] [Abstract][Full Text] [Related]
45. Effects of the Selected Iminosugar Derivatives on Pseudomonas aeruginosa Biofilm Formation. Strus M; Mikołajczyk D; Machul A; Heczko PB; Chronowska A; Stochel G; Gallienne E; Nicolas C; Martin OR; Kyzioł A Microb Drug Resist; 2016 Dec; 22(8):638-645. PubMed ID: 27031025 [TBL] [Abstract][Full Text] [Related]
46. Free tryptophan residues inhibit quorum sensing of Pseudomonas aeruginosa: a potential approach to inhibit the development of microbial biofilm. Chakraborty P; Daware AV; Kumari M; Chatterjee A; Bhattacharyya D; Mitra G; Akhter Y; Bhattacharjee S; Tribedi P Arch Microbiol; 2018 Dec; 200(10):1419-1425. PubMed ID: 30039322 [TBL] [Abstract][Full Text] [Related]
47. Regulation and controlling the motility properties of Pseudomonas aeruginosa. Khan F; Pham DTN; Oloketuyi SF; Kim YM Appl Microbiol Biotechnol; 2020 Jan; 104(1):33-49. PubMed ID: 31768614 [TBL] [Abstract][Full Text] [Related]
48. Bioavailability-enhanced Resveramax™ modulates quorum sensing and inhibits biofilm formation in Pseudomonas aeruginosa PAO1. Vasavi HS; Sudeep HV; Lingaraju HB; Shyam Prasad K Microb Pathog; 2017 Mar; 104():64-71. PubMed ID: 28065820 [TBL] [Abstract][Full Text] [Related]
49. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin. Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241 [TBL] [Abstract][Full Text] [Related]
50. Molecular Determinants of the Thickened Matrix in a Dual-Species Pseudomonas aeruginosa and Enterococcus faecalis Biofilm. Lee K; Lee KM; Kim D; Yoon SS Appl Environ Microbiol; 2017 Nov; 83(21):. PubMed ID: 28842537 [TBL] [Abstract][Full Text] [Related]
51. In-house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition. Ravithej Singh L; Tripathi VC; Raj S; Kumar A; Gupta S; Horam S; Upadhyay A; Kushwaha P; Arockiaraj J; Sashidhara KV; Pasupuleti M Drug Dev Res; 2018 Dec; 79(8):383-390. PubMed ID: 30291767 [TBL] [Abstract][Full Text] [Related]
52. Molecular modeling, synthesis, and screening of new bacterial quorumsensing antagonists. Kim C; Kim J; Park HY; McLean RJ; Kim CK; Jeon J; Yi SS; Kim YG; Lee YS; Yoon J J Microbiol Biotechnol; 2007 Oct; 17(10):1598-606. PubMed ID: 18156774 [TBL] [Abstract][Full Text] [Related]
53. Controlling persister cells of Pseudomonas aeruginosa PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. Pan J; Song F; Ren D Bioorg Med Chem Lett; 2013 Aug; 23(16):4648-51. PubMed ID: 23810498 [TBL] [Abstract][Full Text] [Related]
54. Plant-derived Compounds as Potential Source of Novel Anti-Biofilm Agents Against Pseudomonas aeruginosa. Chung PY Curr Drug Targets; 2017; 18(4):414-420. PubMed ID: 27758704 [TBL] [Abstract][Full Text] [Related]
56. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. LewisOscar F; MubarakAli D; Nithya C; Priyanka R; Gopinath V; Alharbi NS; Thajuddin N Biofouling; 2015; 31(4):379-91. PubMed ID: 26057498 [TBL] [Abstract][Full Text] [Related]
57. Otopathogenic Pseudomonas aeruginosa strains as competent biofilm formers. Wang EW; Jung JY; Pashia ME; Nason R; Scholnick S; Chole RA Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):983-9. PubMed ID: 16301370 [TBL] [Abstract][Full Text] [Related]
58. Quorum-sensing inhibitors as anti-pathogenic drugs. Rasmussen TB; Givskov M Int J Med Microbiol; 2006 Apr; 296(2-3):149-61. PubMed ID: 16503194 [TBL] [Abstract][Full Text] [Related]
59. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Maurice NM; Bedi B; Sadikot RT Am J Respir Cell Mol Biol; 2018 Apr; 58(4):428-439. PubMed ID: 29372812 [TBL] [Abstract][Full Text] [Related]
60. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Davies DG; Parsek MR; Pearson JP; Iglewski BH; Costerton JW; Greenberg EP Science; 1998 Apr; 280(5361):295-8. PubMed ID: 9535661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]